University of Bath

Company

Related News

Chemically Stabilized Peptides Target Undruggable Cancer Drivers

Researchers at the University of Bath have developed a bacterial system that produces, chemically stabilizes, and tests millions of peptide drug candidates inside living cells, identifying inhibitors of transcription factor CREB1 overactive in multiple cancers.

Related Clinical Trials

NCT ID Title Status Phase
NCT07729631

Establishing the Glycaemic Index of Vegetable Smoothies

COMPLETED NA
NCT07724080

Resistance Exercise, IL-7 and Immune Phenotypes in Prostate Cancer

NOT_YET_RECRUITING NA
NCT07675603

Low-carbohydrate Diet and Low-Density Lipoprotein - Cholesterol (LDL-c) Interindividual Variability

RECRUITING NA
NCT07646665

Exogenous Carbohydrate Oxidation During High Intensity Exercise

ACTIVE_NOT_RECRUITING NA
NCT07599683

Effect of Low Dose Galactose on Glycaemia and Glucose Kinetics

RECRUITING NA
NCT07187817

SEquential Treatment of PSoriasis With Biologics

RECRUITING
NCT06844617

A Trial of Staff Time With Proned Patients in the ICU Using the 'BathMat'

COMPLETED NA
NCT06684834

Intermittent Carbohydrate Restriction in Cardiometabolic Health

COMPLETED NA
NCT06668168

The Causal Role of Ketone Bodies in Obesity-associated Disease Prevention - Combining Genetic Epidemiology With a Randomised Trial to Infer Causality

COMPLETED NA
NCT06068803

Do Ketone Drinks Improve Immune, Metabolic and Cognitive Health in Older Adults

COMPLETED NA